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Cutaneous human papillomaviruses (HPVs) include b- and g-HPVs, in addition to a small fraction of a-HPVs.
b-HPVs were first isolated from patients with the rare genetic disorder Epidermodysplasia verruciformis, and
they are associated with the development of nonmelanoma skin cancer at sun-exposed skin sites in these
individuals. Organ transplant recipients also have greater susceptibility to b-HPV infection of the skin and an
increased risk of developing nonmelanoma skin cancer. In both immunosuppressed and immunocompromised
individuals, cutaneous HPVs are ubiquitously disseminated throughout healthy skin and may be an intrinsic part
of the commensal flora. Functional analysis of E6 and E7 proteins of specific cutaneous HPVs has provided a
mechanistic comprehension of how these viruses may induce carcinogenesis. Nevertheless, additional research is
crucial to better understand the pathological implications of the broad distribution of these HPVs.
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’ INTRODUCTION
Human papillomavirus (HPV) represents a diverse group
of viruses infecting mainly epithelial and mucosal tissues (1).
Based on the identity of the L1 major capsid gene sequence,
the majority of the over 200 viral types characterized to date
cluster within the alpha (a)-, beta (b)-, or gamma (g)-HPV
genus (2, 3). While the great majority of a-HPVs are mucosal
types isolated from the anogenital epithelia, some viral types
in this genus (e.g., HPVs 2, 3 and 10) and b- and g-HPVs were
originally designated cutaneous types (Figure 1). To date,
54 b-HPVs (subdivided into 5 species, b1-5) and 98 g-HPVs
(subdivided into 27 species, g1-27) have been fully sequen-
ced and characterized (http://www.nordicehealth.se/hpv
center/reference_clones/), and it is expected that these
numbers will further increase once partial sequences of
putative novel types are described (4). Some cutaneous HPVs
are clearly associated with the development of various skin
lesions, from warts to carcinomas, in restricted populations
(1,5). Nevertheless, it has proven difficult to determine the role
of particular b-HPVs in cutaneous malignancies because of the
high viral diversity and ubiquity of multiple types through-
out healthy skin, the oral cavity, the nasal mucosa and the
anogenital region (6-11).
Prevalence and distribution of cutaneous HPVs
among immunosuppressed individuals
The first record concerning the association of HPV with
papillomatous skin lesions that harbored carcinogenic poten-
tial dates to the early 1920s, when Lewandowsky and Lutz
(12) first described a hereditary condition named Epidermo-
dysplasia verruciformis (EV) that is characterized by extensive
warts throughout the body (Table 1). Later, Jablonska et al.
(13) observed that EV individuals infected with b-HPV 5 and
8 had a higher risk of developing nonmelanoma skin cancer
(NMSC), particularly in ultraviolet (UV)-exposed sites. Toge-
ther, both viral types are detected in approximately 90%
of skin squamous cell carcinomas (SCCs) in EV patients.
In these cases, b-HPVs are actively transcribed and generally
persistent at high copy number (14). Currently, b-HPV 5 and
8 are accepted as possible etiological agents (carcinogen
group 2B) of cutaneous SCC (cSCC) in immunosuppressed
EV individuals by the International Agency for Research on
Cancer (IARC) (15).
In the following years, several studies focused on analyzing
the oncogenic potential of cutaneous HPVs in other immu-
nosuppressed individuals, among which organ transplant
recipients (OTRs) were the most extensively investigated.
OTRs slightly resemble EV patients in that they are often
covered with wart-like skin lesions and actinic keratosis
(AK). Furthermore, OTRs have up to a 100-fold increased
risk of developing NMSC compared to the general popu-
lation (16-17). Importantly, the increased risk of NMSC is
mostly associated with a higher incidence of cSCC (18-20).
Clinical and histological features of these lesions suggest
that cSCCs occasionally develop from viral warts or other
precursor lesions (21,22). NMSC in OTRs often presents as
multiple lesions and is usually confined to UV-exposed
anatomical sites, most likely associated with local immu-
nosuppression (23,24). These tumors are also more aggressiveDOI: 10.6061/clinics/2018/e489s
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Figure 1 - Distribution of cutaneous viral types within different HPV genera. The number of cutaneous viral types within each genus
is indicated.
Table 1 - Select studies on the prevalence and distribution of cutaneous HPVs among immunosuppressed individuals.
Year Author (s) (reference number) Data
1922 Lewandowsky and Lutz (12) First description of epidermodysplasia verruciformis (EV).
1972 Jablonska et al. (13) b-HPVs 5 and 8 infected EV individuals had a higher risk of developing NMSC (after UV exposition).
1974 Koranda et al. (26) Cutaneous warts were detected in 43% of ORT individuals after 3 months to 9 years following transplant.
1976 Mullen et al. (20) Increased risk of NMSC is mostly associated to higher incidence of cSCC.
1977 Hoxtell et al. (19)
1980 Hardie et al. (18)
1978 Sbano et al. (22) cSCC occasionally develop from viral warts or other precursor lesions.
1989 Barr et al. (21)
1980 Hardie et al. (18) The incidence of skin cancer increases 5% per year after the first year of transplant, with a cumulative risk
of 44% after 9 years.
1980 Hardie et al. (18) Tumors are more aggressive in OTRs than in the general population.
1984 Boyle et al. (27) 18% of renal transplant patients who were highly exposed to UV developed carcinogenic lesion in the skin.
1995 Birkeland et al. (16) OTRs have until 100 fold increased risk of developing NMSC as compared to the general population.
2000 Lindelo¨f et al. (17)
1997 Boxman et al. (35) b-HPV is more prevalent in skin warts biopsies than in both the normal skin and plucked hairs among OTRs.
2000 Harwood et al. (36)
2003 Meyer et al. (37)
2000 Antonsson et al. (6) Among OTRs, dialysis patients, and healthy controls, solely the first group reported ever having skin
cancer (11.5%).
2000 Lindelo¨f et al. (17) Within 15 years of transplantation, up to 90% of OTRs develop warts and/or cSCC.
2000 Berkhout et al. (29) Infections of cutaneous HPVs frequently persist in OTRs.
2007 Hazard et al. (30)
2003 Feltkamp et al. (40) There is a positive epidemiological association between b-HPV seroreactivity and cSCC development.
2004 Termorshuizen et al. (24) NMSCs among OTRs are often multiple and usually confined to UV-exposed anatomical sites.
2004 Harwood et al. (34)
2007 Forslund et al. (23)
2005 Weissenborn et al. (46) Data regarding the association between cutaneous HPV infection and cSCC is still inconclusive.
2008 Rollison et al. (45)
2011 Arron et al. (43)
2016 Chahoud et al. (44)
2007 Nindl et al. (28) OTRs have higher cutaneous HPV prevalence rate up to 90% in cSCC compared to the normal skin (11-32%).
2007 Hazard et al. (30) Older ages and history of sunburn are associated to an elevated risk of b-HPV persistent infection.
2014 Hampras et al. (31)
2008 Michael et al. (39) Seroconversion to b-HPV increases with age.
2010 Antonsson et al. (38)
2009 Bouvard et al. (15) b-HPVs 5 and 8 are accepted as possible etiological agents (carcinogens group 2B) of cSCC in
immunosuppressed EV individuals.
2011 Proby et al. (33) Individuals with concordant b-HPV DNA in plucked eyebrow hairs and serologic tests had a significantly
increased risk of developing SCC.
2013 Neale et al. (32) There is a significant association between the number of b-HPVs detected at eyebrow hair follicles and
the increased risk of cSCC among OTRs.
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in OTRs than in the general population and form metastases
more readily (18,25).
Among OTRs, cutaneous warts were detected in 43% of
individuals at 3 months to 9 years following transplant
(25,26). Additionally, within 15 years of transplantation, up
to 90% of OTRs develop warts and/or cSCC (17). Upon ana-
lyzing skin smears from OTRs, dialysis patients and healthy
controls, Antonsson et al. (6) observed that 11.5% of OTRs
reported ever having skin cancer, whereas no cases of NMSC
were observed in the other groups studied. NMSC incidence
in OTRs varies depending on the duration of immunosup-
pression; Hardie et al. (18) demonstrated that the incidence
of skin cancer increased 5% per year after the first year of
transplant, with a cumulative risk of 44% after 9 years.
The incidence of NMSC is also related to long sun expo-
sure. Boyle et al. (27) observed that 18% of renal transplant
patients with high exposure levels to sunshine (43 months
in a tropical or subtropical climate or45 years in an outdoor
occupation) developed carcinogenic alterations in their skin:
two patients were diagnosed with cSCC, and seven were
diagnosed with AK, whereas neither lesion type was noted
in the other patients or in the control group.
Although cumulative sun exposure is the major risk factor
for NMSC, recent studies have revealed a role for HPV as
a cofactor in association with UV radiation in cSCC in OTRs.
OTRs have a higher cutaneous HPV prevalence rate in
cSCC (up to 90%) than in normal skin (11-32%) (28). These
infections frequently persist (29,30), and it has been obser-
ved that older age and a history of sunburn are associated
with an elevated risk of persistent b-HPV infection (30,31).
Furthermore, a significant association between the number of
b-HPVs detected in eyebrow hair follicles and an increased
risk of cSCC was reported among OTRs from Europe (the
Netherlands, the United Kingdom, France and Italy) (32).
Moreover, individuals with concordant b-HPV DNA in pluc-
ked eyebrow hairs and serologic tests had a significantly
increased risk of developing SCC (33).
Among immunosuppressed OTRs, the occurrence of mul-
tiple cutaneous HPV infections is common (34), but high
viral loads were shown to be associated with an increased
risk of SCC development, with total load seemingly more
important than the individual load of any specific type (32).
It should be noted, however, that b-HPV is more highly
prevalent in skin wart biopsies from OTRs than in either
normal skin or plucked hairs from these patients (29,35-37).
Serological studies have also demonstrated that seroconver-
sion to b-HPV increases with age (38,39) and have revealed a
positive epidemiological association between b-HPV seror-
eactivity and cSCC development (40), even though not every
infection is accompanied by a detectable or relevant seroresponse.
Nevertheless, given the high incidence of cSCCs in OTRs,
identifying a clear link between b-HPV infection and cSCC
would have important implications for therapy and preven-
tion (41,42). Therefore, more recent case-control studies are
ongoing, focusing on the association of cutaneous HPV in the
early stages of NMSC carcinogenesis in immunosuppressed
individuals. However, the data are inconclusive (42-46).
Prevalence and distribution of cutaneous HPVs
among immunocompetent individuals
Cutaneous b- and g-HPV DNA can be detected beginning
in early infancy and may be detected in 70% of children by
4 years of age (47). Additionally, b-HPV types detected on
parents are more commonly found on their babies (47,48).
Viral transmission seems to occur inevitably through direct
skin contact (10,49-51), and these viruses have been sug-
gested to be commensal to humans (38,52,53) (Table 2).
Table 2 - Select studies on the prevalence and distribution of cutaneous HPVs among immunocompetent individuals.
Year Author (s) (reference number) Data
1997 Boxman et al. (35) Cutaneous HPVs detection in eyebrow hairs seems to reflect infections in other parts of the body
(useful in epidemiological studies).
2000 Antonsson et al. (6) Sun exposure and history of skin cancer are risk factors associated to b-HPVs detection in IC individuals.
2000 Harwood et al. (36) Cutaneous HPVs prevalence was higher among individuals who reported ever having skin lesions.
2000 Antonsson et al. (6) b-HPV DNA detection and seroprevalence increases with age.
2003 Struijk et al. (56)
2007 Hazard et al. (30)
2009 Weissenborn et al. (48)
2009 de Koning et al. (55)
2003 Antonsson et al. (47) The presence of cutaneous b- and g-HPVs DNA is observed since early infancy.
2003 Antonsson et al. (47) b-HPVs types detected on parents are also more commonly found in their babies.
2009 Weissenborn et al. (48)
2003 Antonsson et al. (52) b- and g-HPVs may be commensal to humans.
2010 Antonsson et al. (38)
2014 Bzhalava et al. (53)
2004 Termorshuizen et al. (24) Severe sunburns are associated with the presence of b-HPV DNA.
2004 Stockfleth et al. (60) HPVs 5 and 8 were the most frequently found in premalignant lesions, SCC and BCC.
2004 Smith et al. (75) Simultaneous oral-genital type-specific b-HPV infections are relatively rare.
2006 Fakhry et al. (73)
2011 Termine et al. (77)
2017 Hampras et al. (74)
2017 Steinau et al. (76)
2017 Nunes et al. (10)
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b-HPVs are widespread in immunocompetent (IC) indivi-
duals within the general population: when plucked hairs
from different body sites are tested, the prevalence is appro-
ximately 90% (54,55). It is believed that cutaneous HPVs
target the hair follicle bulge, which is probably the reservoir
of these viruses (32). Therefore, eyebrow hairs have served as
an easily obtained material for marker analysis in several
epidemiological studies and seem to reflect infection in other
parts of the body (35).
Advanced age has been shown to be the most important
factor influencing the presence of b-HPV DNA in IC indi-
viduals (56,57). Furthermore, sun exposure and a history of
skin cancer are risk factors associated with b-HPV detection
in these individuals (6). For OTRs, some studies have investi-
gated the prevalence of cutaneous HPVs among IC indivi-
duals of different ethnicities and residing under different
climate conditions (52). It was reported that the prevalence of
HPV DNAwas lower in samples from Zambia than in those
Table 2 - Continued.
Year Author (s) (reference number) Data
2005 Weissenborn et al. (46) Higher viral loads are detected within pre-malignant skin lesions as compared to SCC.
2011 Arron et al. (43)
2007 Forslund et al. (23) Most viruses detected on the external skin surface may reflect HPV deposition.
2007 Ko¨hler et al. (54) The prevalence of b-HPVs DNA in plucked hairs from different body sites of IC individuals is
approximatelly 90%.2009 de Koning et al. (55)
2008 Patel et al. (59) b-HPVs may play a role in the pathogeny of NMSC also in healthy individuals.
2008 Feltkamp et al. (49) Viral transmission seems to occur through direct skin contact.
2017 Moscicki et al. (51)
2017 Nunes et al. (10)
2009 Bouvard et al. (15) Epidemiological evidence concerning the association between specific b- and g-HPVs and the development
of skin cancer in IC is inconclusive.
2009 Weissenborn et al. (48) UV radiation may be a putative viral detection-related risk factor.
2010 Antonsson et al. (38) High overall seropositivity (490%) to at least one viral b-HPV is observed within healthy individuals.
2010 Iannacone et al. (62)
2010 Michael et al. (63) Low overall seropositivity to at least one viral b-HPV is observed within healthy individuals.
2011 Proby et al. (33)
2011 Proby et al. (33) b-HPV types most commonly detected in the skin also have the highest seroprevalence.
2011 Bottalico et al. (7) Analysis of b- and g-HPVs DNA and antibodies prevalence among series of samples
(anogenital, oral, skin, nasal cavity from women and men).2013 Forslund et al. (8)
2013 Pierce Campbell et al. (68)
2013 Sichero et al. (65)
2013 Paolini et al. (70)
2014 Hampras et al. (31)
2014 Sichero et al. (66)
2015 Sichero et al. (69)
2015 Dona` et al. (67)
2016 Nunes et al. (9)
2017 Moscicki et al. (51)
2013 Neale et al. (32) Cutaneous HPVs target the hair follicle bulge, which is probably the reservoir of these viruses.
2013 Sichero et al. (65) The majority of male genital samples could not be classified using technologies widely used for typing of a-HPVs.
2013 Pierce Campbell et al. (68) Male external genital lesions (EGL) are not associated to b-HPVs infections.
2016 Rahman et al. (71)
2013 Sichero et al. (65) Most samples from the male genitals were positive for multiples cutaneous HPV DNA.
2014 Sichero et al. (66)
2013 Sichero et al. (65) The detection of b-HPVs in one anatomic site may also represent deposition of virions shed from other
anatomic sites.2014 Sichero et al. (66)
2015 Sichero et al. (69)
2013 Sichero et al. (65) The detection of cutaneous HPVs DNA is not associated to sexual risk factors. Other routes of transmission such
as autoinoculation and non-penetrative sexual activities could be associated.2014 Sichero et al. (66)
2015 Dona` et al. (67)
2015 Torres et al. (72)
2016 Nunes et al. (9)
2016 Chahoud et al. (44) Analyses of association between the detection of antibodies to b-HPVs with SCC risk development.
2017 Hampras et al. (74) The occurrence of concordant b-HPV infections seem to be higher across keratinized tissues than across
mucosal sites.
2017 Moscicki et al. (51) The transmission rate of b-HPVs between anogenital sites from men-to-women and
women-to-men was similar, suggesting these are sexually transmitted.
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collected in Sweden (po0.01) and Bangladesh (po0.05) (52).
b-HPV prevalence and distribution studies have shown that
viral positivity was, on average, higher on the forehead
(36%) and back of the hand (38%) than on the buttocks (26%),
indicating that UV radiation may be a putative risk factor
for viral infection, even though sun exposure data were not
collected in this specific study (48). In fact, severe sunburns
have been associated with the presence of b-HPV DNA (24).
Second-degree burns and repetitive sunburns, with skin
regeneration of the underlying capillary bulb, may result
in the amplification of b-HPV DNA by activating the HPV
life cycle (24). In fact, the risk for SCC development among
Australian or Netherlander IC individuals is higher for those
in which b-HPV DNAwas detected at high loads in plucked
eyebrow hairs (32,56,58).
b-HPV persistence was more commonly observed in adults
(92%) than in children (66%), and although multiple b-HPVs
can infect persistently, no specific type seems to predominate
in such infections (48). Nevertheless, it must be highlighted
that the prevalence of b-HPVs significantly decreases after tape
stripping, indicating that only a small number of epithelial cells
are in fact infected, and most of the detected viruses may reflect
deposition throughout the external skin surface (23).
The IARC recognizes the need for further research on
cutaneous HPVs to better understand the widespread distri-
bution of these viruses. b-HPVs may also play a role in the
pathogeny of NMSC in healthy individuals (59); however,
to date, epidemiological evidence is inconclusive concern-
ing the association between specific b- and g-HPVs and the
development of skin cancer in IC individuals (14,15).
Regarding the HPV status in NMSCs from immunosup-
pressed and IC individuals, viral prevalence was higher in
the former group for all lesion types analyzed: premalignant
lesions (88% among immunosuppressed vs 54% among IC),
SCC (84% vs 27%) and basal cell carcinoma (BCC, 75% vs 36%)
(36). Nevertheless, the prevalence and spectrum of HPV types
detected within the two populations were equivalent among
premalignant lesions, SCC and BCC, and HPVs 5 and 8 were
the most frequently identified types (60). Interestingly, b-HPV
prevalence was reported to be higher in premalignant AK than
in cSCC, and real-time PCR analysis indicated higher viral
loads in premalignant lesions (46) than in SCC, in which viral
load rarely reaches the level of one viral copy per cell (43,46).
This scenario is compatible with a carcinogenic role for HPV
at the early stages of skin carcinogenesis. Because cSCC most
commonly develops in sun-exposed anatomical sites, it is
reasonable to suppose that UV radiation may impede HPV
antigen presentation by suppressing local cell immunity (61).
In addition, several studies have suggested the importance
of b-HPVs as cofactors to UV radiation in the development
of SCC by facilitating the accumulation of UV-induced
mutations, which can ultimately lead to cell transformation.
In addition to HPV DNA detection, the detection of
antibodies to b-HPVs and their association with SCC risk
development have been evaluated in several studies (44).
Nevertheless, overall, serological studies show consider-
able heterogeneity in the results: whereas high overall
seropositivity (490%) to at least one viral b-HPV has been
described (38,62), a lower prevalence is observed in other
studies (33,63). The divergence in the data obtained in
these studies could be attributed not only to differences in
serological methods but also to the range of cutaneous
HPVs tested. With b-HPV DNA detection, the seroprevalence
has been shown to increase with age (6,30,55). Notably, b-HPV
types most commonly detected in the skin have the highest
seroprevalence worldwide (33).
Due to the wide distribution of cutaneous HPVs in the
skin, several groups, including ours, have recently focused
on investigating the distribution of cutaneous HPVs in other
anatomical sites, including the anogenital area. Within the
HIM (HPV Infection in Men) cohort study (64), we initially
observed that most of theB15% of male genital samples that
could not be classified with widely used a-HPV typing
technologies harbored b- and g-HPVs, as evidenced by using
a PCR sequencing protocol (65). We further observed that
most samples were positive for HPV DNA of multiple
cutaneous types using a sensitive Luminex-based methodol-
ogy, suggesting that the former protocol could underestimate
the true prevalence of cutaneous b- and g-HPVs in the male
genital region (65,66). In order to better understand the
prevalence and distribution of cutaneous HPVs, we and
others further analyzed b- and g-HPV DNA and antibodies
by Luminex methodology in a series of samples obtained from
the anogenital region of both men and women (9,51,65-69), the
oral cavity (7,9,70), the skin (31), and the nasal cavity (8).
Taken together, these studies corroborate that cutaneous HPVs
are ubiquitously disseminated throughout healthy skin and
may be an intrinsic part of the commensal flora.
We further observed that male external genital lesions
(EGLs) are not associated with b-HPV infections (68,71) and
that the detection of DNA from these viruses is not asso-
ciated with sexual risk factors, indicating other routes of
transmission, such as autoinoculation and nonpenetrative
sexual activities (9,65-67,72). Alternatively, the detection of
b-HPVs at one anatomic site may indicate the deposition of
virions shed from other anatomic sites (50,65,66,69). Never-
theless, it was recently reported that among heterosexual
couples, the transmission rate of b-HPVs between anogenital
sites was 15.9 per 100 person-months from men-to-women,
with a similar risk for women-to-men transmission, suggesting
that b-HPVs can be sexually transmitted (51). Lastly, the few
reports in which the oral and anogenital regions were analyzed
concurrently indicated that simultaneous oral-genital type-
specific b-HPV infections are relatively rare (10,73-77) but seem
to be higher across keratinized tissues than across mucosal sites
(74). Nevertheless, given the large number of samples and
b-HPV types analyzed, it is unlikely that the same HPV
type will be found at a distant skin site by chance.
Functional analysis of cutaneous HPVs
HPVs are small, nonenveloped viruses with circular
double-stranded DNA of approximately 8000 bp. The viral
genome is divided into three regions: the long control region
(LCR) contains cis-responsive elements for viral and cellu-
lar proteins that regulate viral gene expression and repli-
cation; the early region (E), which encodes proteins crucial
to viral transcription and replication; and the late region
(L), which encodes the viral capsid structural proteins (78-80).
Although the viral genome structure and organization
are highly conserved among HPVs, the LCR of b-HPVs is
shorter than that of a-HPVs, and the E5 gene is absent from
the b-HPV genome (81-83).
The HPV life cycle is tightly associated with the differen-
tiation of the stratified squamous epithelium. HPV infection
begins with entrance of the virus into the basal layer of the
epithelia due to microtrauma (79,84,85). At least for high-risk
a-HPV-infected tissues, the differentiation process is altered
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by expression of the E6 and E7 viral oncoproteins, which
interact principally with the TP53 and pRb suppressor pro-
teins, respectively, but also interact with a broad spectrum
of other cellular proteins, altering the biological properties
of the host cell (79,83,86-89).
As previously discussed in this review, b-HPVs most likely
play a role in the initiation of cSCC rather than in the main-
tenance of the transformed phenotype (14). It is hypothesized
that b-HPV infections destabilize the host genome, allowing
tumors to further develop in the absence of the viral genome
(90-92). Some studies have provided a mechanistic compre-
hension of how these viruses induce carcinogenesis and have
indicated that the biology involved in b-HPV-mediated skin
carcinogenesis differs from that induced by high-risk a-HPVs
(80,91,93,94).
Studies have shown that b-HPVs 38 and 49 are able to
immortalize primary human keratinocytes, whereas HPVs
10, 14, 22, 23, 24 and 36 do not have this ability (95-97). It has
also been reported that transgenic mice expressing the HPV
38 E6 and E7 proteins under control of a keratinocyte-specific
promoter exhibit epidermal hyperplasia and are susceptible
to the development of cutaneous tumors promoted by chemical
carcinogens and UV radiation (98-101). Although the E6
protein from HPVs 8, 24 and 38 binds in vitro to E6-AP
(E6-associated protein), p53 degradation was observed in
the presence of only HPV 49 (95-97,102) (Figure 2). The E6
protein from b-HPVs 5, 8, and 38 attenuates p53 phosphory-
lation and ubiquitination in response to UV exposure,
resulting in less efficient repair of damaged cellular DNA
(90,96). Additionally, HPV 38 induces telomerase by a
mechanism dependent on E6-AP (95). HPV 38 E6 also alters
the capacity of p53 to activate proteins involved in apop-
tosis and suppress proliferation by inducing the accumula-
tion of DNp73, a p53 isoform that antagonizes p53 (96). The
E6 protein from HPVs 5, 8 and 38 was shown to bind p300,
preventing p53 acetylation and p53 -induced repair and
transcriptional transactivation, thus contributing to the accu-
mulation of mutations and chromosomal abnormalities (90).
Furthermore, as with a-HPV, the E6 protein of some
b-HPVs induces BAK degradation, thus preventing the
release of pro-apoptotic mitochondrial factors (103). The inter-
action of E6 with E6-AP is required not only for BAK
degradation but also for hTERT (human telomerase reverse
transcriptase) induction (104,105).
The E7 proteins from the cutaneous HPVs 154, 22, 23, 24,
36, 38 and 49 bind in vitro to pRb but are unable to induce
pRb degradation when expressed in human keratinocytes
(97,106-108) (Figure 2). Nevertheless, in human keratinocytes
transduced with HPV 38 and 39 E6 and E7 proteins, E2F-
induced transcription is likely activated because these viral
proteins induce pRb hyperphosphorylation (80,95,97).
Although most research on oncogenic potential and disease
association has focused on a-HPVs, there is interest in identi-
fying a role of non-a HPV types in the pathogenesis of benign
and malignant lesions (Table 3). Challenges in finding relevant
associations between cutaneous HPV infection and NMSC
Figure 2 - Cellular targets of the E6 and E7 proteins from specific b-HPVs.
Table 3 - Highlights regarding the epidemiology and biology of cutaneous human papillomavirus in immunosuppressed and
immunocompetent individuals.
 b- and g-HPVs, in addition to few a-HPVs are originally designated ‘‘cutaneous types’’.
 The IARC classified b-HPVs 5 and 8 as possible etiological agents of skin SCC in EV individuals.
 OTRs not only have a higher susceptibility to b-HPVs but further attain an ~100 fold increased risk of developing NMSC as compared
to the general population.
 Among OTRs and IC individuals cutaneous HPVs are ubiquitously spread throughout the body and may be an intrinsic part of the commensal flora.
 Although cumulative sun exposure is the major risk factor for NMSC, studies points towards b-HPV infections as co-factors in skin SCC in
association with UV radiation.
 b-HPVs most probably play a role in the initiation of skin SCC rather than in the maintenance of the transformed phenotype.
 Function analysis of E6 and E7 proteins of specific cutaneous HPVs indicate that the biology involved in b-HPV mediated skin carcinogenesis differ from
that induced by high-risk a-HPV types.
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development include the multiplicity and ubiquity of these
viruses throughout the human body, the high probability of
viral transmission (including autoinoculation), and differ-
ences observed in the carcinogenic potential of individual
b-HPVs (Table 4). The last IARC monograph (100B) was
unable to identify consistent epidemiological evidence for
an etiological role attributable to any specific cutaneous HPV
type or species in NMSC development. In addition, biological
mechanisms explaining the oncogenicity of these viruses have
not been fully elucidated.
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